Trial intelligence / Profile preview

Metformin versus placebo for TSH and thyroid volume in adults with prediabetes

IRCT2013121215765N1Phase 3Completed

Sponsor
Isfahan Endocrine and Metabolism Research Center
Start
Apr 2013
Modality
Small Molecules
Countries
1
01

Overview

Phase 3 trial of metformin in prediabetes and thyroid disease (2 arms), sponsored by Isfahan Endocrine and Metabolism Research Center. Primary endpoints: TSH change and Thyroid volume change. Started Apr 2013; status: completed.

02

Drugs

metformin
03

Conditions

prediabetesthyroid disease

Beyond the preview

Go deeper on IRCT2013121215765N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT2013121215765N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call